GURU.Markets stock price, segment price, and overall market index valuation
The company's share price 111 Inc.
111, Inc. is a Chinese digital healthcare platform combining online pharmacy and telemedicine. Its stock price reflects both the enormous potential of the Chinese market and the fierce competition and regulatory pressure.
Share prices of companies in the market segment - Pharmacy
111, Inc. is a Chinese digital healthcare platform that operates an online pharmacy and provides medical consultations. We've categorized it as a "Pharmacy" company. The chart below shows how investors view the digital healthcare and online drug retail sector in China.
Broad Market Index - GURU.Markets
111, Inc. is a leading digital healthcare platform in China, combining online pharmacy, telemedicine, and health data management. Its shares (ADR) are part of the GURU.Markets index. The chart below shows how its performance compares to the overall US market.
Change in the price of a company, segment, and market as a whole per day
YI - Daily change in the company's share price 111 Inc.
The daily price change of 111, Inc., a Chinese digital healthcare platform, reflects the volatility of the country's IT sector. The indicator demonstrates sensitivity to regulatory risks and competition in the online pharmacy market.
Daily change in the price of a set of shares in a market segment - Pharmacy
111, Inc. is a Chinese digital healthcare platform. This chart demonstrates the high volatility of the country's IT sector. Comparing it to YI, with its businesses ranging from online pharmacies to telemedicine, helps assess its regulatory risks.
Daily change in the price of a broad market stock, index - GURU.Markets
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and medical consultations. Its shares reflect both the rapid growth of digital medicine in China and the high regulatory risks that drive significant volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization 111 Inc.
For 111, Inc., year-over-year performance tells the story of its role as a digital pharmacy and healthcare platform in China. Its market capitalization change over the past 12 months reflects its success in creating an integrated system connecting patients, doctors, pharmacies, and pharmaceutical companies, as well as its ability to operate in a highly competitive and regulated environment.
Annual dynamics of market capitalization of the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. The chart below shows how its business, dependent on China's regulatory environment and intense competition, impacts its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
111, Inc., a Chinese digital pharmacy, lives to the rhythm of Beijing's regulatory policies. Its share price (ADR) is driven not by the economy, but by Chinese government decisions on healthcare and fierce competition. The chart tells the story of how technology is transforming a conservative industry amid high risks.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization 111 Inc.
111, Inc. is a Chinese digital pharmacy and healthcare platform. Its monthly performance reflects the growth of its user base, drug sales volumes, and the regulatory environment in China's online healthcare sector. Competition with other major platforms also plays a significant role.
Monthly dynamics of market capitalization of the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, integrating online pharmacy, telemedicine, and data management. The dynamism of this sector reflects the rapid digitalization of Chinese medicine. Against this backdrop, 111, Inc. is building a comprehensive ecosystem, striving to become a one-stop solution for patients, doctors, and pharmaceutical companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
111, Inc. is a leading digital healthcare platform in China, combining online pharmacy, telemedicine, and chronic disease management. Its future depends on regulatory policy and competition in China. The broad market chart (US/global) provides a contrasting backdrop to illustrate how much domestic Chinese factors influenced this digital giant's stock.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization 111 Inc.
111, Inc. is a Chinese digital pharmacy and healthcare platform. Its weekly stock price is sensitive to Beijing's regulatory policies in healthcare and e-commerce, as well as fierce competition in China's vast but complex market.
Weekly dynamics of market capitalization of the market segment - Pharmacy
111, Inc. is a Chinese digital pharmacy and healthcare platform. Its weekly stock price is sensitive to Beijing's regulatory policies in healthcare and e-commerce, as well as fierce competition in China's vast but complex market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
111, Inc., as a Chinese company, has a weak correlation with the US market. Comparing its weekly performance with the S&P 500 reveals this diversification effect. The chart shows how the state of the Chinese economy and regulatory news influence the stock price more than global macroeconomic data.
Market capitalization of the company, segment and market as a whole
YI - Market capitalization of the company 111 Inc.
The market capitalization chart of 111, Inc. tells the story of a Chinese digital pharmacy and healthcare platform. It reflects both the enormous potential of online pharmacy in China, as well as the fierce competition and ongoing regulatory risks.
YI - Share of the company's market capitalization 111 Inc. within the market segment - Pharmacy
111, Inc. is one of the leading digital healthcare platforms in China, combining online pharmacy and telemedicine services. Its market share in its segment's market capitalization reflects its scale. The chart below shows how its weight depends on the regulatory environment and competition in the vast Chinese market.
Market capitalization of the market segment - Pharmacy
111, Inc. is one of the leading digital healthcare platforms in China, combining online pharmacy and medical consultations. The chart below shows the total market capitalization of the pharmaceutical sector, illustrating the widespread digitalization of healthcare in China.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows an online pharmacy from China. 111, Inc. is one of the leading platforms that sells medications and provides online medical consultations. Its line reflects both the enormous potential of digital healthcare and China's strict regulatory environment.
Book value capitalization of the company, segment and market as a whole
YI - Book value capitalization of the company 111 Inc.
111, Inc.'s book value is determined by its integrated online and offline healthcare and pharmacy platform in China. This represents complex digital and logistics capital. The chart below shows how the company manages its capital while building a "digital pharmacy" and medical hub for millions of patients in the vast Chinese market.
YI - Share of the company's book capitalization 111 Inc. within the market segment - Pharmacy
111, Inc. is a Chinese digital healthcare platform that combines online pharmacy and medical services. Its physical assets include large pharmacy warehouses. The chart shows the company's share of the online pharmacy logistics infrastructure.
Market segment balance sheet capitalization - Pharmacy
Online pharmacy, as the BCap_Ges chart for retail shows, is a hybrid sector. 111, Inc., operating in China, combines a "light" IT platform with the "heavy" need to manage physical logistics and warehouses for drug delivery.
Book value of all companies included in the broad market index - GURU.Markets
The book value of 111, Inc. is the massive automated warehouses and logistics network for an online pharmacy in China. This reflects the colossal physical scale of the infrastructure, which allows for the storage and delivery of millions of packages of physical, tangible medications across the country.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - 111 Inc.
111, Inc. is one of the leading digital pharmacies and healthcare platforms in China. Its value lies in its technology platform and logistics network. MvsBCap's performance will reflect its ability to compete in China's vast but complex healthcare market, as well as all the regulatory risks associated with this sector.
Market to book capitalization ratio in a market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, connecting pharmacies, doctors, and patients. Its value lies in its vast network. The chart shows how the market views its ecosystem and potential in the vast Chinese market.
Market to book capitalization ratio for the market as a whole
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. Its value lies in its vast ecosystem. The chart shows how the market perceives the potential for healthcare digitalization in China, while also taking into account the high regulatory and competitive risks.
Debts of the company, segment and market as a whole
YI - Company debts 111 Inc.
111, Inc., a Chinese online pharmacy and healthcare platform, uses capital to manage its massive drug inventory, develop its logistics network, and maintain its technology platform. This chart shows how the company finances its complex operations as it strives to digitize China's conservative pharmaceutical market.
Market segment debts - Pharmacy
111, Inc. is a digital healthcare platform in China that combines online pharmacy and medical consultations. Developing such a comprehensive service requires significant investment in logistics, technology, and partnerships. The chart below shows how the company is funding the development of its large-scale digital healthcare ecosystem.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio 111 Inc.
111, Inc. (Yi Yao, Inc.) is a large online pharmacy and medical platform in China. This chart shows how the company uses debt to manage its massive inventory and logistics. In a highly competitive environment and facing pricing pressure from regulators, high debt can impact profitability.
Market segment debt to market segment book capitalization - Pharmacy
111, Inc. is a leading digital healthcare platform in China, combining online pharmacy and medical consultations. The chart shows the overall debt burden in the sector. It helps assess how the company finances its complex ecosystem and competition in China's rapidly growing but highly regulated digital healthcare market.
Debt to book value of all companies in the market
111, Inc. operates one of China's leading digital healthcare platforms, integrating online pharmacy, telemedicine, and chronic disease management. This graph, reflecting the overall state of the economy, influences consumer healthcare spending. The population's ability to pay and the growth of the middle class are driving digital healthcare.
P/E of the company, segment and market as a whole
P/E - 111 Inc.
This chart from 111, Inc., a Chinese online pharmacy and telemedicine platform, reflects the market's assessment of healthcare digitalization in China. Its dynamics demonstrate investors' confidence in the long-term growth of online drug sales and medical consultations, while accounting for fierce competition and regulatory risks.
P/E of the market segment - Pharmacy
This chart shows the average price-to-earnings ratio for the digital health sector in China, where 111, Inc. operates. The ratio reflects both high growth potential and regulatory risks. It provides context for assessing how the market weighs these factors for online pharmacy 111, Inc.
P/E of the market as a whole
111, Inc. is one of the leading digital healthcare platforms in China. It operates an online pharmacy and provides medical consultations by connecting patients, doctors, and pharmacies. This chart reflects the state of the healthcare sector in China. It helps understand how the company competes in the vast but strictly regulated digital healthcare market and the risks the market is factoring into its valuation.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company 111 Inc.
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and chronic disease management. This chart reflects analysts' expectations for the future growth of digital healthcare in China and the company's ability to monetize its ecosystem.
%20P%2FE%20111%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-111-Inc.&v=1772638504018 "Chart of the company's future (projected) P/E 111 Inc.")
Future (projected) P/E of the market segment - Pharmacy
111, Inc. operates one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and chronic disease management. This chart shows how its future revenue expectations compare to the industry average, reflecting its role in digitizing China's vast healthcare market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharmacy&v=1772638504021 "Future (projected) P/E graph of the market segment - Pharmacy")
Future (projected) P/E of the market as a whole
111, Inc. is one of the leading digital healthcare platforms in China. It combines online pharmacy and telemedicine. Its growth depends on the speed of healthcare digitalization in the country. This chart, reflecting global sentiment, influences investor interest in the Chinese tech sector and the valuation of companies like 111, Inc.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772638504028 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit 111 Inc.
111, Inc. operates one of the largest online pharmacies and healthcare platforms in China. The company's profits depend on the sales volume of medications and medical services through its platform. This chart illustrates how digitalization and deregulation are transforming China's vast healthcare market, creating opportunities for players like 111.
Profit of companies in the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, operating an online pharmacy and providing telemedicine services. The company is part of the rapidly growing "digital health" market. This graph reflects the transformation of the healthcare system, where online services are making medical care and medications more accessible to millions of people.
Overall market profit
111, Inc. is a digital healthcare platform in China that connects pharmacies, doctors, and patients. Its growth is driven by the pace of digitalization in medicine and rising healthcare costs. This chart, in the context of China, reflects rising affluence, which is driving this process.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company 111 Inc.
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and chronic disease management. This chart summarizes analyst forecasts, reflecting the ongoing digitalization of China's healthcare system and the profitability of the company's business model.
%20profit%20of%20the%20company%20111%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-111-Inc.&v=1772638504429 "Graph of future (projected) profit of the company 111 Inc.")
Future (predicted) profit of companies in the market segment - Pharmacy
111, Inc. is one of the leading digital healthcare platforms in China. It operates an online pharmacy and provides medical consultations by connecting patients with doctors and pharmacists. This chart shows profitability forecasts for the healthcare sector, reflecting the rapid digitalization of medical services in one of the world's largest markets.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharmacy&v=1772638504498 "Graph of future (predicted) profits of companies in a market segment - Pharmacy")
Future (predicted) profit of the market as a whole
111, Inc. is a digital healthcare platform in China, combining online pharmacy and medical consultations. Its growth depends on the pace of healthcare digitalization and consumer spending. This chart, reflecting global trends, provides context for understanding China's economic development, which determines the effective demand for the company's services.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772638504552 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - 111 Inc.
111, Inc. is a digital healthcare platform in China that combines online pharmacy and medical services. This chart shows how the market values its model. The ratio reflects its share of China's vast digital healthcare market and its potential for growth.
P/S market segment - Pharmacy
111, Inc. operates an integrated online and offline healthcare and pharmacy platform in China. This chart shows the average revenue estimate for the healthcare and e-commerce sectors. It helps understand how investors view the company's ability to provide comprehensive services, from online consultations to drug delivery, in the vast Chinese market.
P/S of the market as a whole
111, Inc. is one of the leading digital healthcare platforms in China, operating an online pharmacy and providing online medical services. Their business straddles the intersection of e-commerce and healthcare. This chart, showing the average market revenue estimate, helps understand how investors view the digital healthcare sector in China.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company 111 Inc.
111, Inc. operates one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and chronic disease management. This chart reflects investor expectations for the digitalization of Chinese healthcare. The valuation is based on user growth and drug sales volume through its platform.
%20P%2FS%20111%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-111-Inc.&v=1772638504698 "The graph of the company's future (projected) P/S 111 Inc.")
Future (projected) P/S of the market segment - Pharmacy
111, Inc. is a leading digital healthcare platform in China, combining online pharmacy, telemedicine, and health data management. This chart shows how investors view its integrated model in China's vast and growing healthcare sector.
%20P%2FS%20market%20segment%20graph%20-%20Pharmacy&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharmacy&v=1772638504757 "Future (projected) P/S market segment graph - Pharmacy")
Future (projected) P/S of the market as a whole
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. This chart, reflecting expectations for the growth of the digital economy and healthcare spending in China, is a dual driver for 111. Rising incomes and internet penetration are driving a shift toward online medication purchases and medical consultations.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772638504804 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales 111 Inc.
111, Inc. operates one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine services. This chart shows revenue from sales of medications and other medical products. The growth here reflects the widespread shift of China's healthcare system to an online environment.
Sales of companies in the market segment - Pharmacy
111, Inc. is one of the leading digital healthcare platforms in China. Its business is divided into two main segments: "B2C," which includes an online pharmacy and medical consultations for consumers, and "B2B," which provides services to pharmacies and clinics. This chart shows revenue from one of these segments, reflecting the growth of digital medicine.
Overall market sales
111, Inc. is one of the leading digital pharmacies and healthcare platforms in China. It integrates online medication sales, medical consultations, and chronic disease management. The company's growth reflects the trend toward digitalization of healthcare in China, supported by both government policy and changing consumer habits.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company 111 Inc.
111, Inc. is one of the leading digital healthcare platforms in China, operating an online pharmacy and providing medical consultations. Its revenue forecast is based on sales of medications and other medical products, reflecting the growth of e-commerce in Chinese healthcare.
%20sales%20of%20the%20company%20111%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-111-Inc.&v=1772638504858 "Schedule of future (projected) sales of the company 111 Inc.")
Future (projected) sales of companies in the market segment - Pharmacy
111, Inc. is one of the leading integrated online healthcare platforms in China, integrating pharmacy, telemedicine, and health management. This chart reflects expectations for the entire pharmacy sector. It helps assess the growth rates analysts predict for online drug sales and healthcare digitalization in China.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharmacy&v=1772638504870 "Schedule of future (projected) sales of companies in the market segment - Pharmacy")
Future (projected) sales of the market as a whole
111, Inc., a Chinese online pharmacy and healthcare platform, is driving its growth, driven by increased e-commerce penetration in the pharmaceutical industry and rising healthcare spending. This chart of overall sales forecasts reflects the economic health driving both of these trends.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772638504889 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality 111 Inc.
111, Inc. is a leading digital healthcare platform in China, integrating online pharmacy, telemedicine, and data management. This chart illustrates the company's challenging path to profitability in a vast but competitive sector. It reflects its ability to monetize its ecosystem by converting revenue from drug and service sales into net profit.
Market segment marginality - Pharmacy
111, Inc. operates one of the leading digital healthcare platforms in China, combining online pharmacy, telemedicine, and data management. Profitability in this complex ecosystem depends on synergies between services and efficient logistics. The chart shows how successful their integrated model is compared to competitors.
Market marginality as a whole
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and data management. Profitability depends on the scale of its ecosystem. This chart shows overall profitability, but for YI, the trend toward digitalization of healthcare in the vast Chinese market creates unique growth opportunities.
Employees in the company, segment and market as a whole
Number of employees in the company 111 Inc.
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. This graph shows a massive team of pharmacists, doctors, and IT specialists. The size of the team reflects the scale of this integrated model, serving millions of patients.
Share of the company's employees 111 Inc. within the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. Serving millions of patients requires a massive team. This statistic demonstrates its enormous scale as an employer in China's digital healthcare sector.
Number of employees in the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and medical consultations. This chart shows employment in the pharmaceutical and healthcare sectors. The growth in the number of pharmacists and IT specialists in this field reflects the rapid digitalization of access to medicines and medical services in China.
Number of employees in the market as a whole
111, Inc. is a digital healthcare platform in China. Demand for online pharmacies and telemedicine in the country is growing explosively. This chart reflects the situation in the US, but for 111, the digitalization of healthcare and the growth of the middle class in China are more important, as they are driving its development.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company 111 Inc. (YI)
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. The high market capitalization per employee in this chart is typical for successful tech platforms, where a small team creates a product serving millions of patients and doctors.
%20of%20the%20company%20111%20Inc.%20(YI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-111-Inc.-YI&v=1772638505072 "Chart of market capitalization per employee (in thousands of dollars) of the company 111 Inc. (YI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharmacy
111, Inc. operates one of the leading digital healthcare platforms in China, connecting pharmacies, doctors, and patients. For such an ecosystem, this metric reflects its scalability and network effects. How effectively can a company manage such a complex system while generating high cost per employee?
%20by%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharmacy&v=1772638505093 "Market capitalization per employee (in thousands of dollars) by market segment - Pharmacy")
Market capitalization per employee (in thousands of dollars) for the overall market
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy, telemedicine, and chronic disease management. The chart shows how the market is valuing this comprehensive and scalable digital healthcare model.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772638505165 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company 111 Inc. (YI)
111, Inc. (YI) is a leading digital healthcare platform in China. They operate an online pharmacy (B2C) and provide technology solutions for hospitals and offline pharmacies (B2B). This chart shows how effectively they manage this complex ecosystem, measuring their ability to generate revenue from drug sales and technology services.
%20Chart%20111%20Inc.%20(YI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-111-Inc.-YI&v=1772638505195 "Company Profit Per Employee (in thousands of dollars) Chart 111 Inc. (YI)")
Profit per employee (in thousands of dollars) in the market segment - Pharmacy
111, Inc. is one of China's leading digital healthcare platforms, integrating online pharmacy, telemedicine, and data management. Scalability and operational efficiency are crucial in HealthTech. This chart shows how efficiently the company's team generates revenue while managing a complex digital ecosystem, compared to the industry benchmark.
%20in%20the%20market%20segment%20-%20Pharmacy&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharmacy&v=1772638505291 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharmacy")
Profit per employee (in thousands of dollars) for the market as a whole
111, Inc. (YI) is a Chinese "digital pharmacy," an online platform for selling medications and medical services. It's a hybrid of e-commerce and telemedicine. Its profit per employee reflects the efficiency of its logistics, platform, and team of doctors/pharmacists in serving a huge customer base.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772638505429 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee 111 Inc. (YI)
111, Inc. is one of China's leading digital healthcare platforms, combining online pharmacy and telemedicine. This chart demonstrates the effectiveness of its integrated model. High revenue per employee is achieved by serving millions of patients and processing a huge volume of orders.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-111-Inc.-YI&v=1772638505502 "Sales chart per company employee 111 Inc. (YI)")
Sales per employee in the market segment - Pharmacy
111, Inc. (YI) is a leading digital healthcare platform in China. They combine online pharmacy, telemedicine, and chronic disease management. This chart compares 111 Inc.'s revenue per employee to the industry average, demonstrating the effectiveness of their integrated digital healthcare model.
Sales per employee for the market as a whole
111, Inc. (YI) is one of the leading digital healthcare platforms in China. They operate an online pharmacy and provide telemedicine services, connecting patients, doctors, and pharmacies. They are a scalable IT platform. This chart shows the revenue (from drug sales and services) generated by their platform per employee.
Short shares by company, segment and market as a whole
Shares shorted by company 111 Inc. (YI)
111, Inc. (YI) is a Chinese "digital pharmacy," one of the largest online platforms for selling medications and medical services. This sector is under close scrutiny from Beijing regulators. This chart shows the number of investors betting that the authorities will tighten the screws and limit the profitability of online pharmacies.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-111-Inc.-YI&v=1772638505605 "Short Shares Chart for the Company 111 Inc. (YI)")
Shares shorted by market segment - Pharmacy
111, Inc. (YI) is one of China's leading digital healthcare platforms. They operate an online pharmacy and provide telemedicine services. This chart shows bets against the "Chinese e-health" sector. It reflects investor concerns about regulatory pressure and low margins in the online pharmacy business.
Shares shorted by the overall market
111, Inc. operates a large Chinese online pharmacy and telemedicine platform. While healthcare is a defensive sector, YI is a tech company operating in China's complex regulatory environment. This chart illustrates the overall market pessimism. When fear mounts, investors flee geopolitical risks. Chinese stocks, regardless of sector, are often sold off as investors flee to the safety of American assets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator 111 Inc. (YI)
111, Inc. (YI) operates one of the largest online pharmacies and healthcare platforms in China. This business is highly dependent on consumer demand and regulatory changes. This oscillator helps gauge the strength of current market sentiment. A rise above 70 may indicate a peak in buying enthusiasm, while a drop below 30 signals a possible seller overreaction.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-111-Inc.-YI&v=1772638505696 "RSI 14 indicator chart for the company's stock 111 Inc. (YI)")
RSI 14 Market Segment - Pharmacy
111 (YI) is a giant digital health "bridge" in China, operating one of the country's largest online pharmacies. Their success is a balance between technology and strict government regulation. This chart measures the collective "pulse" of the entire pharmacy sector. It helps investors understand whether YI's performance is driven by unique regulatory news from China or whether the entire global industry is overheated or oversold.
RSI 14 for the overall market
For 111, Inc., a Chinese online pharmacy, this chart reflects consumer sentiment and risk appetite. During periods of market euphoria, consumers are more willing to spend on "non-essential" dietary supplements and health products. During times of panic (and economic downturn in China), they save, and investors flee Chinese stocks, which is a double whammy.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast YI (111 Inc.)
111, Inc. (YI) is a leading Chinese digital healthcare company. It operates a large online pharmacy (B2C) and a B2B platform that supplies thousands of brick-and-mortar pharmacies. This chart shows the average price target from analysts assessing the growth of pharmaceutical e-commerce and regulatory risks in China.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-YI-111-Inc.&v=1772638505789 "A chart showing analyst consensus forecasts for the expected stock price. YI (111 Inc.)")
The difference between the consensus estimate and the actual stock price YI (111 Inc.)
111, Inc. is one of the leading digital players in Chinese healthcare. The company operates an online pharmacy and provides a B2B platform for clinics. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe they can grow in China's complex e-health regulatory environment.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-YI-111-Inc.&v=1772638505883 "A chart showing the difference between the consensus forecast and the actual stock price. YI (111 Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharmacy
111, Inc. (YI) is one of the leading digital pharmacies in China. The platform connects patients, doctors, and pharmacies, offering online consultations and medication delivery. This chart shows analysts' overall expectations for the pharmacy sector, reflecting whether experts believe the e-health market in China will grow.
Analysts' consensus forecast for the overall market share price
111, Inc. (YI) is a Chinese "digital pharmacy." They operate a giant online marketplace that connects pharmacies, doctors, and patients, delivering medications to their homes. This chart shows the overall risk appetite, reflecting investors' willingness to invest in companies operating in China's complex and regulated healthcare sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index 111 Inc.
111, Inc. (YI) is a pharmacy and doctor in China's pocket. It is one of the leading digital healthcare platforms in China, combining online pharmacy (D2C), telemedicine, and B2B drug distribution for pharmacies. This chart is a barometer of Chinese digital health. It reflects their enormous sales volume (GMV) and their total dependence on Beijing's complex regulatory policies.
AKIMA Market Segment Index - Pharmacy
111, Inc. (YI) is one of the leading digital healthcare platforms in China. They operate an online pharmacy (B2C) and provide technology solutions (B2B) for pharmacies, doctors, and pharmaceutical companies. The chart shows the average index for the segment, helping investors assess how well YI competes in the massive Chinese e-health market compared to the average.
The AKIM Index for the overall market
111, Inc. is China's leading digital healthcare platform and online pharmacy. It connects patients, doctors, and the pharmaceutical industry. This chart, showing the average (global/US) market share, serves as a benchmark. It helps assess how YI, a major telemedicine player, stacks up against overall macroeconomic trends.
